Which of the following best accounts for the Swiss pharmaceutical companies choosing to invest in small U.S. biogenetics companies?
A. To gain access to US natural resources
B. To gain access to the US market
C. To gain access to research in this area
D. To gain access to a brand name
E. To gain access to US skilled labor
Answer: C